Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Noah Syndergaard

Noah Syndergaard Scratched With Biceps Discomfort

By | at

The Mets have scratched star righty Noah Syndergaard from his scheduled start today, manager Terry Collins told reporters including MLB.com’s Anthony DiComo (Twitter links) and SNY’s Steve Gelbs (via Twitter). Syndergaard is dealing with discomfort in his right biceps, likely caused by tendinitis, leading to what Collins phrased a “tired arm.”

At this time, it’s not known whether this is more than a single-start blip, or whether there’s cause for greater concern. The Mets will surely take a cautious route regardless; as Collins put it, “we can’t take a chance on this guy.”

Matt Harvey will take the ball in Syndergaard’s place. This is the second time that Harvey has been moved up to cover for an injury. Fortunately, the last time, Jacob deGrom needed only a bit of extra rest. Harvey, deGrom, and Syndergaard have been excellent even as the club has staggered to an 8-12 record to open the year. Clearly, the Mets can scarcely afford to lose any of the three; though it’s plenty early, the club is already 6.5 games back of the Nationals in the NL East.

It’s certainly possible that Syndergaard could follow deGrom in making a swift return. Indeed, Syndergaard could be cleared to throw by this weekend, which seems to be his own expectation. (Twitter links via DiComo.) But the organization has ordered up an MRI to make sure there isn’t a more significant problem causing the discomfort.

More broadly, rotation depth continues to be a concern for the Mets, who received a dud of an outing last night from Robert Gsellman. He and Zack Wheeler haven’t produced quite the results hoped for, though their peripherals suggest cause for optimism moving forward. Of greater concern, the organization seemingly still doesn’t know when it’ll welcome back Steven Matz and Seth Lugo to the rotation mix.

Latest On Mets’ Pitching Injuries

By | at

The Mets enjoyed a solid Opening Day win today on the back of a strong performance from starter Noah Syndergaard. But there are some new health concerns for the team’s pitching staff — though their gravity isn’t yet clear.

Syndergaard himself departed after six innings with a blister, as Kristie Ackert of the New York Daily News writes. It’s not expected to be a major issue, but the team is looking to get out ahead of things by giving him an added day of rest. Blisters can turn into significant injuries, to be sure, but there’s no reason at this point to think it’s more than a minor issue to be managed.

There’s more worry with lefty Steven Matz, who is already on the DL with elbow inflammation. The team’s position remains that he has been cleared of structural damage, as Marc Carig of Newsday reports, but Matz provided further information on the issue. He says that he has been diagnosed with a flexor tendon strain, which would seem to be a distinct injury from the bone chips that he had surgically removed over the offseason. Regardless, his timeline will surely be dictated by how he feels and what kind of progress the doctors observe, but the news adds to the 25-year-old’s growing list of arm ailments in his young career.

In theory, any such gaps in pitching coverage were to be covered by Seth Lugo, who filled in with aplomb last year. But as John Harper of the New York Daily News reports, manager Terry Collins hinted after today’s game that there may be some concern with Lugo’s status. “We lost Seth Lugo today for a period of time,” said Collins, who later added that “it’s going to be a couple of weeks, for sure,” before Lugo is able to return. There are no known details to this point, but clearly the Mets are anticipating that they won’t be able to use the 27-year-old for at least some fairly significant stretch.

In light of these new concerns, Collins stressed the need to maintain the health of the current five-man rotation, which explains the proactive move to get Syndergaard extra rest. As Harper notes, resurgent righty Rafael Montero — who’s currently operating out of the MLB bullpen — now seems to occupy a position of much greater importance than had been anticipated. If there’s a silver lining to this early test of the organization’s pitching depth, it’s that they had so much to begin with, so the current roster is still stocked with high-quality starters.

Pre-Arb Contracts Of Note: Correa, Syndergaard, Turner

By | at

Every team takes a different approach to the negotiation of contracts with players who have yet to qualify for arbitration. Technically, there’s no obligation to pay them any more than the league minimum salary, which currently sits at $535K. But all teams make some allowance for increases above that amount. Some use formulas with varying inputs; others appear largely ad hoc. Some range well over the minimum; others allow for only de minimis bumps. Read here for more on the process; better still, check out Zach Links’s reporting on the subject from early 2014.

We already learned recently of one notable 2017 pre-arb contract situation, as the Red Sox elected to renew Mookie Betts. A renewal occurs when the club can’t get the player to agree to the salary. The result is the same — the player gets what the team is willing to give — but the player gets to make clear his disapproval. In that case, Betts still received a relatively massive payday, with his $950K salary trailing only Mike Trout (in 2014) among pre-arb players.

Here are a few more notable salaries that have been reported since:

  • The Astros ended up renewing their own pre-arb star, Carlos Correa, per Jon Heyman of Fan Rag. But he’ll get quite a bit less than Betts; in fact, for the second straight year, Correa will earn only the league-minimum rate of pay. (To be fair, he’s also one service class behind Betts.) As MLBTR previously reported, Houston has in prior years utilized a formula-based system that allows players to earn relatively meager boosts over the minimum, though it’s not known whether that specific approach is still followed. Clearly, though, Correa — one of the game’s most exciting young talents — would have been offered at least something more than the minimum. Presumably, then, he was docked back down owing to his refusal to sign, which is another element the Astros have reportedly employed. It obviously remains to be seen whether there’ll be any long-term strain on the relationship between player and team, but it’s not hard to see the possibility.
  • There’s perhaps less cause for angst between the Mets and young ace Noah Syndergaard, who’ll earn $605,500 in 2016 with his renewal, as Heyman tweets. That’s certainly a reasonably significant increase over the minimum, and it falls in line with the team’s prior approach to setting arb salaries, as Joel Sherman of the New York Post reports. Syndergaard was hoping to earn a bit more, and declined to sign on to the team’s offer, but New York did not apply any penalty in setting the renewal price. It seems that the relationship between player and team remains harmonious, per Sherman. Syndergaard, unlike Correa, can also look forward to much higher earnings in the near future, as he’s nearly certain to achieve Super Two status.
  • Finally, the Nationals have agreed to a $554,900 salary with emergent star Trea Turner, according to Heyman (via Twitter). That’s rather a healthy rate of pay for a player who’ll enter the year with just 135 days of service, though Turner’s outstanding half-season of work in 2016 — .342/.370/.567 with 13 home runs and 33 steals over 324 plate appearances — more than justifies such an increase. With Turner’s deal in the books, the Nats were able to line up with all 22 of their arb-eligible players. Looking ahead for the youngster, who’ll be moving back to his accustomed shortstop position this year, the biggest impact on his earnings (beyond his play) won’t be the team’s decision on how much to pay him before he reaches arbitration. Instead, it’ll be whether he can qualify for Super Two status. Without a 2015 cameo in the books, he wouldn’t have much of a shot; as things stand, he’ll be touch-and-go to reach arb eligibility a year ahead of the pack.

Latest On Mets’ Extension Candidates

By | at

9:10pm: While a long-term deal with Walker remains possible, it doesn’t seem likely that the Mets will pursue extensions with any of their young starters, Carig reports in a full column. None of Jacob deGrom, Noah Syndergaard, Steven Matz or Matt Harvey has approached the team about a long-term deal, and the Mets haven’t been especially proactive in initiating talks given recent injury issues for most of their young arms.

With the exception of Syndergaard, who reportedly pitched much of 2016 with a small bone spur in his right elbow, each of the other three arms is fewer than nine months removed from notable surgery.

Harvey underwent an operation to remove a rib in order to alleviate thoracic outlet syndrome last summer, while deGrom had his ulnar nerve repaired shortly thereafter. Matz went under the knife to remove more significant bone spurs than the one that briefly troubled Syndergaard, and he had shoulder issues late in the 2016 season as well.

10:54am: When he accepted the Mets’ $17.2MM qualifying offer last fall, second baseman Neil Walker resolved his status for the coming season, but both he and the club left open the possibility of reaching a longer-term accommodation. While there’s no agreement as yet, the sides have continued to discuss a new contract in the ensuing months, Walker told reporters including MLB.com’s Anthony DiComo (Twitter links).

Citing the “potential” for a long-term accord, the 31-year-old switch hitter seemingly suggested that there will be an ongoing effort over the course of the spring to pursue a deal. As Marc Carig of Newsday notes on Twitter, it appears that the “situation looks favorable” for the sides to come together and once again keep Walker from reaching the open market. Indeed they almost reached a three-year pact when Walker was weighing the qualifying offer, according to a report from Kristie Ackert of the New York Daily News. And the sides continued talking later in the offseason, Carig adds via Twitter. Both reporters peg the general contract chatter in the three-year, $40MM range.

The veteran second baseman also noted that he’s preparing to try out some other infield positions this spring. He’ll spend at least some time at both third and first base, it seems, which could expand his and the organization’s options in the near term and beyond. With David Wright’s health still a question mark moving forward and Lucas Duda set to hit the open market after the 2017 campaign, Walker could conceivably become a factor in the corner infield at some point.

Beyond those two spots, the Mets are largely unsettled in the middle infield beyond the coming season. The club holds an option over shortstop Asdrubal Cabrera and will hope to see continued strides from prospects Amed Rosario and Gavin Cecchini, though it’s still possible to imagine a need at that position in 2018. Both Walker and Jose Reyes are slated for free agency next fall, and the club dealt away one possible replacement in Dilson Herrera. Though Wilmer Flores remains an option around the infield, he has mostly been utilized in a part-time role, and it’s likely that the organization sees other possibilities such as T.J. Rivera and Matt Reynolds in a similar light.

Given that mix, it’s not surprising to hear that New York has interest in retaining Walker for the future. He has a lengthy track record of steadily above-average offensive production, drew some of the best grades of his career for his fielding in 2016, and says he’s feeling better than he has in quite some time since undergoing season-ending back surgery late last season. Of course, the sides will need to settle on a price and term of years; the single-season QO value is a lofty target for an average payout, though perhaps Walker could command something approaching that level over three or (much less likely) four years. Recent deals that could provide guidance include those reached between Justin Turner and the Dodgers (four years, $64MM), Daniel Murphy and the Nationals (three years, $37.5MM), and Ben Zobrist and the Cubs (four years, $56MM).

No Plans For Syndergaard, Cabrera To Undergo Offseason Surgery

By | at

OCT. 11: Kristie Ackert of the New York Daily News reports that shortstop Asdrubal Cabrera will not require offseason surgery, either. Cabrera met with doctors following the Mets’ elimination from the Wild Card game for an evaluation of a knee injury that he played through for the majority of the season, and surgery was reportedly a possible outcome. Instead, he’ll take an additional two weeks of rest before beginning his offseason regime, which will be monitored by medical officials over the course of the winter to ensure that his left patellar tendon is properly healed.

Cabrera will play out the second season of a two-year, $18.5MM contract with the Mets in 2017, and the Mets also hold an affordable club option over his services for the 2018 campaign. That contract looks to be one of the offseason’s biggest bargains, in retrospect, as Cabrera batted .280/.336/.474 with 23 home runs, 30 doubles and a triple over the course of the season en route to a season that both Fangraphs and Baseball-Reference pegged at roughly three wins above replacement. He’ll earn $25MM over three years if that 2018 option is exercised next winter.

OCT. 10: Though it was revealed during the season that Noah Syndergaard had been diagnosed with a bone spur, he won’t require offseason surgery to correct the issue, per ESPNNewYork.com’s Adam Rubin (Twitter link). That has generally been the expectation since the news trickled out in late June.

It is certainly a good sign for the Mets that Syndergaard will enter spring camp next year after a normal winter. He ended up with only a modest increase in innings on the year. The 24-year-old ultimately tossed 190 2/3 innings after his appearance in the NLDS, but had already racked up 179 2/3 frames in 2015 (including his five Triple-A starts).

New York is no doubt hoping that the outstanding Syndergaard will not only remain in good health, but will be joined in that classification by his rotation mates. Steven Matz recently had his own, much more significant bone spur removed in a procedure recently. Jacob deGrom’s season ended early when he checked in for a surgery in which his ulnar nerve was re-positioned. And, of course, Matt Harvey is the biggest question mark of all after undergoing a procedure to address thoracic outlet syndrome.

Syndergaard is now the unquestioned ace of the staff after posting a 2.60 ERA with 10.7 K/9 against 2.1 BB/9. While it seems reasonable to expect Matz and deGrom to line up behind him, the remainder of the rotation is a bit uncertain. Zack Wheeler is still an option but he hasn’t thrown since 2014 and hasn’t enjoyed a straightforward return from Tommy John surgery. Robert Gsellman and Seth Lugo both showed well in limited outings, but haven’t yet fully established themselves in the majors. The only Mets hurler who didn’t miss a start was 43-year-old Bartolo Colon, who spun 191 2/3 innings of 3.43 ERA ball, but he’s a free agent. Given the state of affairs, it wouldn’t be surprising to see the team move to keep him in the fold for a fourth-straight campaign.

Yoenis Cespedes, Noah Syndergaard Leave Game With Apparent Injuries

By | at

11:12pm: Both players suggested that there isn’t cause for alarm after the game, as Rubin reports. Syndergaard said he did not experience any elbow pain, but was dealing with “a little shoulder fatigue.”

Cespedes, meanwhile, said that he’s dealt with a similar issue and only missed a handful of days. He expressed hope that he’d avoid a DL stint. Skipper Terry Collins also sounded an optimistic tone, saying that the club would likely just go with a short-handed roster for the time being rather than rushing into any DL determinations.

10:14pm: Manager Terry Collins explains: “[Syndergaard] just said his arm went dead. It got tired on him.” (Via Rubin, on Twitter).

9:23pm: Syndergaard was suffering from “arm fatigue” when he was pulled, the Mets announced. The issue was “not elbow-related.”

8:19pm: Already dealing with the loss of Matt Harvey for the year, the Mets now have to new injury situations to watch. Star center fielder Yoenis Cespedes left the action with what’s being called a quadriceps strain, while budding staff ace Noah Syndergaard left in the middle of the fifth inning with an unknown malady.

It’s far too soon to know whether either player could be dealing with a significant issue, but the surrounding circumstances add to the concern. And that’s all before considering the fact that these two players have been the organization’s two best through the first half of the season.

In the case of Cespedes, ESPNNewYork.com’s Adam Rubin suggests on Twitter that the quick diagnosis of a strain — not a “mild” strain, or discomfort, say — is unusual for the tight-lipped organization. A full analysis will be required before the team will know more, but there’s at least some cause for added attention.

That’s all the more true for Syndergaard. While we’ve heard both team and player downplay the issue, he has dealt with a barking elbow at various points of the season. Syndergaard has a reputedly small bone spur, which is hardly uncommon, but this isn’t the first time he’s been pulled early. Something obviously triggered the move, as Syndergaard was pulled in the middle of the fifth inning while sitting at just 79 pitches. James Wagner of the New York Times tweets that his final two fastballs clocked in at 95 and 94 mph, which is well below his ridiculous 98+ average velocity but perhaps isn’t overly concerning in and of itself.

Alderson On Matz, Syndergaard, Duda, Gurriel, Reyes

By | at

Mets general manager Sandy Alderson met with the media in New York today to address a number of topics, including health updates on starters Noah Syndergaard and Steven Matz, each of whom was reported to have a bone spur in his pitching elbow yesterday. Per Newsday’s Marc Carig (links to Twitter), Alderson said that club doctors aren’t worried about the spur in Syndergaard’s right elbow becoming worse, and the New York Post’s Mike Puma tweets that Syndergaard’s spur is much smaller than the spur in Matz’s elbow. Accordingly, the outlook on Matz was painted a bit more grimly, with Alderson somewhat stating, “He’ll either pitch and be able to tolerate the discomfort, or he won’t.” As Puma tweets, surgery to remove the spur would sideline Matz for three months, so he’ll look to continue pitching for the time being.

Matz won’t need to be skipped on a regular basis, though, tweets ESPN New York’s Adam Rubin. However, the team might eventually move to a six-man rotation. Presumably, said mix would include right-hander Zack Wheeler, though Alderson said that while he’ll soon have a new projection for Wheeler’s return, he does not have a new one at this tme (via Carig). Logan Verrett is another option to get some starts, and he’ll take the hill Wednesday in place of Matz, as Matz will be bumped back to Thursday, per Rubin.

The rotation, of course, is far from the only area in which the Mets are dealing with injuries. First baseman Lucas Duda hasn’t suited up for a game since May 20 due to a stress fracture in his back, and he’s still at least two weeks away from even resuming baseball activities (Twitter link via MLB.com’s Anthony DiComo). As such, the earliest possible return date for Duda would seem to be August.

Looking across the diamond, David Wright’s season could very well be over following neck surgery, and Alderson confirmed that the club worked out Cuban star Yulieski Gurriel, who could seemingly step in as an eventual alternative to the Mets’ longtime captain. Gurriel didn’t face live pitching in his workout, but he did run “fairly well,” per Alderson, and he also took batting practice and worked out in the field at both third base and second base (links to Carig on Twitter). They’re still weighing whether to make an offer, DiComo tweets, and it should be stressed that Gurriel is by no means an immediate replacement; it’s been months since Gurriel saw regular action in a game setting, and as such he’d need to spend a month ramping up in the minor leagues, in the Mets’ estimation.

In the meantime, the Mets have enlisted a different infield alternative by bringing Jose Reyes back to Queens on a minor league deal. He’s working exclusively at third base in the minors, according to Alderson, but upon his promotion to the big leagues he’ll begin working out in the outfield as well (via Rubin). The addition of Reyes doesn’t in any way preclude the team from signing Gurriel as well, Carig notes. Of course, the Mets will have to deal with a number of other clubs should they elect to make a serious run at Gurriel. He’s reportedly worked out for the heavy-spending Dodgers already, and he’s also been connected to the likes of the Astros, Giants and Yankees in recent weeks since being declared a free agent by MLB.

Steven Matz, Noah Syndergaard Both Pitching With Bone Spurs

By | at

10:49pm: Noah Syndergaard is also pitching with a spur in his right elbow, Ackert reports. Though he denied that in his comments after his start tonight, multiple other reports suggest that it is indeed an issue, and Mike Puma of the New York Post tweets that the club is not acknowledging the spur at the pitcher’s preference.

Though Syndergaard was working in the triple digits in his outing against the Nationals, he seemed to be struggling with control. The big righty ultimately departed after just three innings of work having allowed a season-high five earned runs and three walks.

Syndergaard recently experienced discomfort that led to an MRI, but was given a clean bill of health. As with Matz, it seems that the spur is mostly a matter of tolerating pain and avoiding changes to mechanics that could lead to broader problems.

It’s important to emphasize that bone spurs are fairly common and aren’t necessarily major concerns if they do not cause ligament issues. And there’s no indication in his case that surgery is on the table at the moment in Syndergaard’s case. Ackert does note that the expectation is that both pitchers will ultimately require procedures — with hopes that they can be delayed until the season is over.

As for Matz, he has been battling through the issue for over a month and has been treated with a cortisone shot at some point, Jon Heyman of todaysknuckleball.com writes. The spur is “not small” and is quite painful, and Heyman suggests that there’s at least some concern that continuing to pitch through it could contribute to a more serious injury. Matz himself is said to be uncertain at this time whether to elect surgery.

4:43pm: Mets southpaw Steven Matz has been diagnosed with a bone spur in his pitching elbow, as Kristie Ackert of the New York Daily News reports on Twitter. The club is not only considering whether or not he’ll make his next start, but is assessing whether a surgical option will be pursued, per Marc Carig of Newsday (Twitter link).

GM Sandy Alderson will participate in a meeting to work through the options, per Carig’s report. The possibility of a procedure is just that at present, as no decisions have been made, but it appears to be very much on the table. While there’s no concern that pitching through the pain would lead to injury, at least directly, the club is said to be concerned that the pain has impacted his performance. Ackert notes that an operation after the season is also a possibility.

In the event that Matz does go under the knife in the near-term, Carig tweets, it would likely be six weeks before he is even able to begin throwing. He’d surely require a throwing program and rehab assignment from that point forward. While a precise timeline is difficult to guess, it could certainly represent a lengthy absence.

Matz had bounced back from a rough first start to post a long string of excellent outings — nine straight, in fact, in which he did not allow more than two earned runs. But things have been somewhat uneven in his three most recent starts, and his last effort set off some alarm bells. Matz not only allowed six earned runs, but failed to record a single strikeout in 4 1/3 innings. Glancing through the excellent Brooks Baseball database, it seems that Matz’s vertical release has dropped over the course of the season, though it’s unclear whether that’s connected at all.

This news represents another red flag for a Mets pitching staff that remains one of the game’s best. But heavy usage last season has, perhaps, shown up in several areas. Jacob deGrom isn’t throwing as hard, Noah Syndergaard has had a balky elbow, and Matt Harvey just hasn’t been his dominant self. The results are still excellent, on the whole, and it surely doesn’t hurt that Bartolo Colon has been magnificent while Zack Wheeler remains on the comeback trail (though the latter has been slowed of late). At the same time, there’s certainly some cause for concern with Matz, in particular — all the more so given that he dealt with lat issues in 2015.

East Notes: Red Sox Outfield, Phillies, Syndergaard, Teheran

By | at

Red Sox outfielder Chris Young hit the DL with a hamstring injury, as Chris Mason of the Boston Herald writes. He joins Brock Holt and Blake Swihart as unavailable left field options for Boston, which already had ample justification to pursue an upgrade at the position. There’s some optimism for both of those players, at least, as Holt has begun a rehab assignment and Swihart is out of his walking boot.

Here’s more from the eastern divisions:

  • The Red Sox are stretched thin in left even as Rusney Castillo looks less and less like a viable major leaguer. Rob Bradford of WEEI.com takes an interesting look at the process that led the team to sign him to a contract that now seems like an expensive miss.
  • Phillies GM Matt Klentak says that the “feeling out process” has begun for summer trade activity, as Corey Seidman of CSNPhilly.com reports. Still, he suggests that it’s largely been quiet for Philly thus far. Klentak also discussed the progress of top prospect J.P. Crawford, explaining that some early struggles at Triple-A are just part of the maturation process and noting that he has continued to exhibit a mastery of the strike zone.
  • The Mets appear to believe that Noah Syndergaard’s valuable right elbow isn’t at risk despite a recent scare, as MLB.com’s Anthony DiComo reports. An MRI showed only inflammation, and manager Terry Collins noted that Syndergaard has dealth with minor flare-ups at times in the past without any real structural issue arising. He’s set to make his next scheduled start.
  • Over at Fangraphs, Eno Sarris explores an important question for the Braves as well as potential suitors for righty Julio Teheran: just how good is he? He suggests that Teheran may be able to continue to outperform ERA estimators somewhat, though perhaps some movement toward those marks is to be expected. In the end, Sarris calls him “a good pitcher on a great contract,” which seems like a fair appraisal.

NL Notes: Syndergaard, Cespedes, Dodgers, Myers, Gray, Cards

By | at

The Mets and their fans had a scare earlier today when both Noah Syndergaard and Yoenis Cespedes departed from a game early, but the team gave fairly positive updates on that pair and on Zack Wheeler tonight (links to Twitter via David Lennon of Newsday). There’s no structural damage in Syndergaard’s elbow. He’s free to resume his normal routine and will begin taking some anti-inflammatory medication to help with the discomfort he’s experienced twice this season. Cespedes received a cortisone shot for a sprained left wrist but is day to day and isn’t headed to the disabled list at this time. Wheeler, too, received a cortisone shot for a nerve issue in his elbow but has no structural damage.

As Mets fans breathe a sigh of relief, here are a few other notes from around the Senior Circuit…

  • Ken Rosenthal of FOX Sports points out that the Dodgers spent more on international amateurs (players that fall within international signing guidelines) than six organizations spent on their Major League payroll to open the season. Los Angeles spent about $96MM this period ($48MM on players plus about $48MM in luxury taxes), and that figure doesn’t even factor in the six-year, $30MM deal signed by right-hander Yaisel Sierra. Rosenthal spoke to commissioner Rob Manfred about the Dodgers’ spending, and Manfred said that there will be a strong focus on changes to the international system in the upcoming wave of CBA negotiations. “…when you see that kind of disparity in any part of the system, it generally suggests to us that the system is not functioning in a way that promotes competitive balance,” said the commissioner. “Rest assured, we’re going to be making proposals to address that.”
  • The Padres remain “active” in trade talks, per Jon Morosi of MLB.com (via Twitter), but one name that hasn’t seen much chatter is Wil Myers. It seems that San Diego is not terribly interested in discussing the outfielder/first baseman. The 25-year-old will hit arbitration eligibility after the season, and will be in line for a nice payday if he can keep hitting at anything like his current .290/.336/.529 pace. Myers has already knocked a career-high 16 long balls in 301 plate appearances, and finally seems to be coming into his own after inconsistency and injury issues in recent years. San Diego paid a high price to get Myers before the 2015 season, with talented young players Joe Ross and Trea Turner moving to D.C. in a notable three-team swap, and it appears for now as if the club would like to see its investment pay off on the field rather than cashing him in for prospects.
  • The Rockies pulled Jon Gray from today’s start with what the team is terming “arm fatigue,” and he’ll be reevaluated tomorrow, writes Nick Groke of the Denver Post. Gray threw just 40 of his 80 pitches for strikes and admitted that he’s felt some fatigue in his arm for his past couple of outings, but “it’s just now getting to a serious point.” Manager Walt Weiss said that Gray’s arm felt “heavy” today, and the right-hander himself said he had more trouble with his control than he ever has. “I’ve never had great control, but this, I didn’t know where this was going,” he said. “I wanted to leave it all out there and grind through it, but it wasn’t working.”
  • Brayan Pena is nearing the end of his 20-day rehab window with the Cardinals, writes Derrick Goold of the St. Louis Post-Dispatch, which could mean that the team will part ways with veteran backup Eric Fryer. The 30-year-old Fryer has been great in a very limited role with St. Louis, hitting .406/.457/.469 in just 35 plate appearances (despite appearing in 22 games). However, Pena is on a two-year contract signed with the Cardinals last offseason, so even though he’s struggled through 11 rehab games as he recovers from knee surgery, he figures to be in the team’s plans.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top